Most Likely Diagnosis: Bacterial Gastroenteritis (Shigella or Salmonella)
In a 2-month-old infant with bloody mucoid stools, numerous active pus cells, no constitutional symptoms, and slow response to ceftriaxone but not cefixime, the most likely diagnosis is bacterial gastroenteritis, specifically Shigella or Salmonella infection. The clinical presentation and antibiotic response pattern strongly suggest a bacterial etiology requiring third-generation cephalosporin therapy 1.
Clinical Reasoning
Why Bacterial Infection is Most Likely
The key diagnostic features pointing to bacterial gastroenteritis include:
- Numerous active pus cells in stool - This indicates acute inflammatory colitis, characteristic of invasive bacterial pathogens
- Blood and mucus per rectum - Classic presentation of bacillary dysentery
- Age < 3 months - This age group warrants empiric antibacterial therapy for bloody diarrhea with suspected bacterial etiology 1
- Response to ceftriaxone but not cefixime - Suggests a pathogen requiring parenteral third-generation cephalosporin coverage
Specific Pathogens to Consider
Shigella is the most likely culprit given:
- Frequent bloody mucoid stools (bacillary dysentery pattern)
- Numerous pus cells indicating invasive colitis
- Absence of fever (constitutional symptoms can be minimal in young infants) 2
Salmonella (nontyphoidal) is the second consideration:
- Can present with bloody stools in neonates
- Requires treatment in infants < 3 months due to risk of invasive disease 1, 2
Campylobacter jejuni is also possible but less likely given the slow response pattern 2, 3.
Why Ceftriaxone Works but Cefixime Doesn't
The differential response reveals important pharmacological distinctions:
- Ceftriaxone (IV/IM) achieves higher tissue concentrations and has better penetration into inflamed intestinal mucosa 4
- Cefixime (oral) has only 40-50% bioavailability and may not achieve adequate intestinal tissue levels in severe colitis 5
- For infants < 3 months with bacterial bloody diarrhea, parenteral third-generation cephalosporins are specifically recommended over oral agents 1
Diagnostic Approach
Immediate investigations needed:
- Stool culture for Salmonella, Shigella, Campylobacter, and Yersinia 1
- Blood cultures - Mandatory in infants < 3 months with bloody diarrhea due to risk of bacteremia 1
- Complete blood count - Look for leukocytosis (>20,000 cells/μL suggests severe bacterial infection) 1
- Stool for C. difficile testing - Though less common in this age group, recent antibiotic exposure warrants testing 6, 7
Alternative Diagnoses to Exclude
Less Likely but Important Considerations:
Clostridioides difficile colitis - Possible given antibiotic exposure (cefixime), but:
- Typically presents with watery diarrhea, not predominantly bloody stools 4
- Recent case reports show it can present with bloody stools and pseudomembranes in infants 6
- The slow response to ceftriaxone argues against this (ceftriaxone can worsen C. difficile) 8
Food protein-induced allergic proctocolitis (FPIAP) - Unlikely because:
- Usually presents with well-appearing infants and minimal symptoms 9, 3
- Does NOT typically show numerous active pus cells 3
- Would not respond to antibiotics 9
Non-allergic benign infantile proctocolitis - Excluded by:
- Presence of numerous pus cells (suggests infection, not benign inflammation) 9
- Need for antibiotic therapy 9
Necrotizing enterocolitis (NEC) - Less likely because:
- Patient lacks constitutional symptoms and appears well 10
- More common in preterm infants, though can occur in term infants 7
- Would expect more systemic signs 10
Treatment Recommendations
Continue ceftriaxone as empiric therapy while awaiting culture results 1:
- Dose: 50-75 mg/kg/day IV once daily (not to exceed 2 grams) 4
- Duration: Continue for at least 2 days after symptoms resolve, typically 4-14 days total 4
- Infusion time: Administer over 60 minutes in neonates to reduce bilirubin encephalopathy risk 4
Modify therapy based on culture results 1:
- If Shigella: Consider azithromycin as alternative (5-10 mg/kg/day for 3 days) 1
- If Salmonella: Continue ceftriaxone for full course given age < 3 months 1
- If Campylobacter: Switch to azithromycin (10 mg/kg/day for 3 days) 1
Critical Pitfalls to Avoid
Do NOT use oral cefixime for infants < 3 months with invasive bacterial colitis - Inadequate tissue penetration and bioavailability 1, 5
Do NOT withhold antibiotics pending culture results in infants < 3 months with bloody diarrhea and pus cells - This age group requires empiric coverage 1
Do NOT assume cow's milk allergy without excluding bacterial infection first - The numerous pus cells strongly suggest infection 3
Monitor for dehydration - Assess fluid and electrolyte balance regularly 1
Avoid fluoroquinolones - Not recommended in pediatric patients due to cartilage toxicity concerns 1
If STEC suspected, avoid antibiotics - But this is unlikely given the clinical response to ceftriaxone and absence of hemolytic uremic syndrome features 1
Follow-Up Management
- Reassess at 48-72 hours - If no improvement, consider C. difficile colitis, parasitic infection (rare at this age), or non-infectious causes 1, 11
- Repeat stool examination if symptoms persist beyond 14 days 1
- Consider colonoscopy only if diagnosis remains unclear and symptoms persist despite appropriate therapy 3
- Public health notification - Report culture-confirmed Shigella or Salmonella to local health authorities 1